Tower Research Capital LLC (TRC) - KEMPHARM INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of KEMPHARM INC
ValueSharesWeighting
Q3 2023$19,897
+58.7%
4,128
+67.9%
0.00%
Q2 2023$12,541
+16847.3%
2,459
-84.7%
0.00%
-100.0%
Q4 2022$74
-99.8%
16,026
+165.3%
0.00%
+200.0%
Q3 2022$38,000
+35.7%
6,041
-3.7%
0.00%0.0%
Q2 2022$28,000
-80.3%
6,274
-77.8%
0.00%0.0%
Q1 2022$142,000
-6.0%
28,243
+62.8%
0.00%
-66.7%
Q4 2021$151,000
+619.0%
17,347
+688.1%
0.00%
+200.0%
Q3 2021$21,000
-12.5%
2,201
+15.5%
0.00%0.0%
Q2 2021$24,000
-96.0%
1,906
-97.1%
0.00%
-90.0%
Q1 2021$597,00064,9850.01%
Other shareholders
KEMPHARM INC shareholders Q4 2023
NameSharesValueWeighting ↓
Ground Swell Capital, LLC 14,219$131,0000.42%
Arete Wealth Advisors, LLC 52,844$486,0000.06%
SG3 Management, LLC 187,100$1,721,0000.04%
Pensionmark Financial Group, LLC 13,850$118,0000.03%
Virtu Financial LLC 38,196$351,0000.02%
CNB Bank 3,000$28,0000.02%
HAP Trading, LLC 110,200$295,0000.02%
Engineers Gate Manager LP 31,700$292,0000.01%
Harel Insurance Investments & Financial Services Ltd. 20,000$615,0000.01%
Tower Research Capital LLC (TRC) 64,985$597,0000.01%
View complete list of KEMPHARM INC shareholders